Pantoprazole As Kalceks (Pantoprazole)

Pantoprazole is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions:

• Gastro‑oesophageal reflux disease (GERD): Improves symptoms and promotes healing of the oesophageal lining.
• Erosive oesophagitis: Heals erosive damage to the oesophagus caused by acid reflux.
• Peptic ulcer disease: Facilitates ulcer healing and reduces recurrence.
• Zollinger‑Ellison syndrome: Controls excessive gastric acid production associated with this rare endocrine disorder.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the parietal cell surface of the stomach lining. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid secretion, leading to a sustained reduction in gastric acidity and providing an environment that supports mucosal healing.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Abdominal pain or discomfort.
• Nausea or vomiting.
• Flatulence or bloating.
• Constipation.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
• Clostridioides difficile‑associated colitis.
• Low magnesium levels (hypomagnesemia) with prolonged use.
• Acute interstitial nephritis.
• Fracture risk with long‑term high‑dose therapy.
• Liver enzyme elevations indicating possible hepatitis.

Before initiating therapy, consider the following safety points:

• Assess renal function: dose adjustment may be required in severe impairment.
• Review concomitant medications: potential for drug‑drug interactions.
• Monitor magnesium levels: especially during long‑term treatment.
• Evaluate bone health: prolonged use may affect calcium balance.
• Pregnancy and lactation: use only if clearly needed.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption and efficacy.
• HIV protease inhibitors (ritonavir, atazanavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely)

• Antiplatelet drug clopidogrel: possible reduction in antiplatelet effect.
• Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
• Methotrexate: increased serum levels, especially with high‑dose regimens.
• Digoxin: may increase serum concentration.
• Oral contraceptives: potential reduction in hormonal efficacy.